Croda International PLC
30 July 2003
Wednesday, 30 July 2003
Croda International Plc
Interim Results Announcement 2003
Croda today announces its interim results for the six months to 30 June 2003:
Highlights
2003 2002
Sales for continuing operations £150.1m £151.4m
Pre-tax profit before exceptional items for
continuing operations £20.6m £19.3m
Profit before taxation £20.0m £0.3m
Earnings per share - basic 9.9p (3.7p)
Earnings per share - before exceptional items 9.9p 9.3p
Dividends per share 4.02p 3.91p
• Sales volumes in core Personal and Health Care markets up by 3%
• Pre-tax profit before exceptionals for continuing operations up 6.7%
• Oleochemicals trading margin raised to over 17%
• Ongoing demand good and product pipeline strong
• Net debt reduced by over £8m
• Interim dividend increased by 2.8% to 4.02p
Commenting on the results, Chairman, Antony Beevor, said:
'Following the strong start to the year in our core business, demand has
remained firm in most areas. Sales volumes in Personal and Health Care, which
represent 56% of our total sales, rose by 3%. A strong performance in active
ingredients, mix improvements and price increases raised margins in the
Oleochemicals business to over 17%.
Our new product programmes continue with a number of launches planned for the
second half of this year and into 2004. Consequently the Board remains
confident that we will make progress in the current year.'
For further information, please contact:
Mike Humphrey, Chief Executive Tel: 01405 860551
Barbara Richmond, Group Finance Director Tel: 01405 860551
Charlie Armitstead, Financial Dynamics Tel: 0207 269 7182
Or visit our web site at: www.croda.com where the presentation to analysts will
be available by midday today.
Chairman's Statement
Profit before tax for continuing operations in the first half year was £20.6m,
6.7% ahead of the same period last year.
Sales from continuing operations in the first six months were in line with those
for the previous year. The negative effect of currency fluctuations and our
withdrawal from certain commodity business was offset by volume growth in our
core markets, improved product mix, and price increases in a number of business
areas.
The tax rate was 35.5% giving earnings per share of 9.9p, a 6.5% increase on the
comparable number excluding exceptional items of 9.3p (basic loss per share of
3.7p) for 2002. The Board has declared an increased interim dividend of 4.02p
(2002 3.91p), payable to shareholders on 5 January 2004.
Trading
Following the good start to the year, demand remained firm in most areas with
the exception of the United States of America, where there was some slow down
towards the end of the first half. A strong performance in active ingredients,
mix improvements and price increases raised margins in the Oleochemicals
business to over 17%.
Sales volumes in Personal and Health Care, which represent 56% of our continuing
sales, rose by 3% and continue to be the main driver of growth for the Group.
Sales in the Home Care and Plastics Additives segment fell as we withdrew from
some lower margin commodity products.
In our Other businesses, sales again declined. Our Technical Oils business
withdrew from certain commodity products following the restructuring of that
business. However, for the first time in a number of years profits in these
businesses did not decline, but held steady at £1.7m.
The loss on discontinued operations represents the final trading losses in our
gelatin business which closed earlier this year.
Finance
In the first half year we spent £4.4m on capital investment. In addition we
sold our Market Harborough site which was closed at the end of last year. The
proceeds of this disposal were £1.2m. The resulting low net capital
expenditure, combined with the improved results and continued progress on
working capital produced a net cash inflow of £7.1m. The overall reduction in
net debt was even higher at £8.4m, as a consequence of a large proportion of our
debt being denominated in US dollars, giving gearing of 25% (2002 37%).
Outlook
Demand remains good overall. Our new product programmes continue with a number
of launches planned for the second half of this year and into 2004.
Consequently the Board remains confident that we will make progress in the
current year.
Croda International Plc
Results for the six months ended 30 June 2003
Group profit and loss account
Unaudited £m 2003 2002 2002
First First Full
half half Year
Turnover
Continuing operations 150.1 151.4 295.0
Discontinued operations 4.0 11.1 18.6
______ ______ ______
154.1 162.5 313.6
______ ______ ______
Operating profit
Continuing operations 22.3 21.6 42.3
Discontinued operations (0.6) (0.1) (2.0)
______ ______ ______
21.7 21.5 40.3
Exceptional items - (18.9) (28.9)
Net interest payable (1.7) (2.3) (4.0)
______ ______ ______
Profit before taxation 20.0 0.3 7.4
UK taxation (1.0) (1.4) (1.6)
Overseas taxation (6.1) (5.5) (11.4)
Tax on exceptional items - 1.8 5.0
______ ______ ______
Profit after taxation 12.9 (4.8) (0.6)
Minority interests and
preference dividends - (0.1) (0.1)
______ ______ ______
Profit attributable to ordinary
shareholders 12.9 (4.9) (0.7)
Ordinary dividends (5.2) (5.1) (15.0)
______ ______ ______
Reserves transfer 7.7 (10.0) (15.7)
______ ______ ______
pence per pence per pence per
share share share
Earnings per share of 10p
Basic 9.9 (3.7) (0.5)
Basic before exceptional items 9.9 9.3 17.7
Diluted 9.9 (3.7) (0.5)
Diluted before exceptional items 9.9 9.3 17.7
Ordinary dividends
Interim 4.02 3.91 3.91
Final 7.59
Summarised balance sheet
Unaudited £m At At At
30 June 30 June 31 December
2003 2002 2002
Fixed Assets 169.8 185.0 173.3
Stock 52.7 59.1 51.5
Debtors 97.4 96.8 89.7
Creditors and provisions (104.3) (107.8) (99.6)
______ _______ ______
215.6 233.1 214.9
______ _______ _______
Shareholders' funds 170.7 168.6 161.7
Minority Interests 1.2 1.2 1.1
______ ______ ______
171.9 169.8 162.8
Net debt 43.7 63.3 52.1
______ ______ ______
215.6 233.1 214.9
______ ______ ______
Movement in shareholders' funds
Unaudited £m 2003 2002 2002
First First Year
Half Half
Profit attributable to ordinary shareholders 12.9 (4.9) (0.7)
Ordinary dividends (5.2) (5.1) (15.0)
Goodwill written back - 5.2 5.2
Currency translation differences 1.3 (0.4) (1.6)
______ ______ ______
Net movement in shareholders' funds 9.0 (5.2) (12.1)
Opening shareholders' funds 161.7 173.8 173.8
______ ______ ______
Closing shareholders' funds 170.7 168.6 161.7
______ ______ ______
Note
There have been no recognised gains or losses, other than those detailed above,
since 31 December 2002.
Summarised cash flow
Unaudited £m 2003 2002 2002
First First Year
Half Half
Operating profit 21.7 21.5 40.3
Depreciation 7.2 7.9 15.7
Amortisation of goodwill and own shares 0.3 0.2 0.6
Working capital movement 0.3 (7.0) 1.4
Other (3.8) (1.8) (6.4)
_____ _____ _____
Operating cash flow 25.7 20.8 51.6
Interest (1.7) (2.3) (3.9)
Dividends (5.1) (5.1) (14.8)
Taxation (7.0) (6.9) (10.7)
Fixed assets purchased (4.4) (8.5) (13.9)
Net purchase of own shares (0.6) (0.3) (0.8)
Disposals 1.7 0.3 0.7
Other (1.5) 0.8 (0.2)
_____ _____ _____
Movement in net debt from cash flows 7.1 (1.2) 8.0
New finance lease contracts - - (0.2)
Exchange differences 1.3 1.5 3.7
_____ _____ _____
Movement in net debt in the period 8.4 0.3 11.5
_____ _____ _____
Exceptional items
Unaudited £m 2003 2002 2002
First First Year
Half Half
Loss on discontinuance of operations
Loss on discontinuance - (13.7) (23.7)
Goodwill written back - (5.2) (5.2)
_____ _____ _____
- (18.9) (28.9)
_____ _____ _____
Segmental analysis of continuing operations
Unaudited £m 2003 2002 2002
First First Year
Half Half
Turnover by business sector
Oleochemicals 133.4 133.3 260.1
Other 16.7 18.1 34.9
_____ ______ ______
150.1 151.4 295.0
_____ ______ ______
Trading profit
Oleochemicals 23.1 22.2 43.4
Other 1.7 1.7 3.4
_____ ______ ______
24.8 23.9 46.8
Central costs (2.5) (2.3) (4.5)
_____ ______ ______
22.3 21.6 42.3
_____ ______ ______
Turnover by geographical destination
United Kingdom 22.9 25.1 50.2
Rest of Europe 48.8 40.2 81.4
Americas 45.6 52.1 97.5
Asia 19.3 20.2 39.6
Rest of World 13.5 13.8 26.3
_____ ______ ______
150.1 151.4 295.0
_____ _____ ______
Turnover by market sector
Personal and Health Care 83.7 82.9 160.7
Home Care and Plastics Additives 21.5 22.4 43.7
Industrial Specialities 28.2 28.0 55.7
Other 16.7 18.1 34.9
_____ ______ ______
150.1 151.4 295.0
_____ ______ ______
Notes to the interim report
1. The interim dividend of 4.02p will be paid on 5 January 2004 to
shareholders registered on 5 December 2003.
2. The interim financial information has been prepared on the basis of the
accounting policies set out in the Group's 2002 statutory accounts.
3. The financial information for the year ended 31 December 2002 is
abridged. Full accounts for that year, on which the Auditors of the
Company made an unqualified report, have been delivered to the Registrar of
Companies.
4. This statement has been sent to all shareholders and can be obtained by
the public from the Company's registered office, Cowick Hall, Snaith, Goole,
East Yorkshire DN14 9AA.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.